info icon

This is a non-core endpoint: only basic statistics are computed.

Insulin, intermediate and long-acting

INSULIN_INTER_AND_LONG

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Medicine purchases: ATC A10AE01|A10AE0[4-6]|A10AE30

1 out of 7 registries used, show all original rules.

21122

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

21122

diagram downward connector

Include endpoints None

21122

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

20429

diagram downward connector
INSULIN_INTER_AND_LONG

Control definitions

Control exclude INSULINS

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 20429 8601 11828
Unadjusted prevalence (%) 5.42 4.08 7.11
Mean age at first event (years) 53.54 50.88 55.48

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: INSULIN_INTER_AND_LONG – Insulin, intermediate and long-acting
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Insulin, intermediate and long-acting

Endpoint not on priority list, no data to show.